Friday, November 22, 2024
11/22/2024
Project Summary DEAF1-associated neurodevelopmental disorder (DAND) is a phenotypic spectrum of features that include intellectual disability and autism spectrum disorder (ASD). Individuals with DAND have clinical phenotypes that overlap with other neurodevelopmental disorders including Angelman and Rett syndromes. DAND is caused by single allelic de novo and bi-allelic heritable mutations in the DEAF1 gene. Our functional studies indicate that identified de novo mutations disrupt DEAF1 transcriptional activity and suggest that the mutations are dominant negative. The effects of heritable variants on DEAF1 function remain unclear. This proposal focuses on two identified DEAF1 variants, p.Q264P (de novo) and p.R226W (heritable). The resultant spectrum disorders of individuals with heritable and de novo DEAF1 mutations is remarkably quite similar. We hypothesize there is a common set of altered DEAF1 target genes, caused by the heritable and de novo DEAF1 mutations, that underlie the pathogenesis of DAND. The innovation of this proposal is the development of new model systems that more closely represent DAND. The current best model for assessing the effects of decreased DEAF1 activity on cognitive function is a conditional knockout model. Although the knockout model demonstrates the importance of DEAF1 expression in learning and memory, it does not mirror the allelic profile of DAND or, more importantly, account for dominant negative or possible gain-of-function actions of the mutant DEAF1 proteins. We will use CRISPR/Cas9-mediated genomic engineering to develop p.R227W and p.Q265P (analogous to p.R226W and p.Q264P in humans) point mutation knock-in mouse models of DAND. Neurobehavioral testing will assess the effects of mutant DEAF1 proteins on learning and memory. We will also identify transcriptomic changes in postnatal developing and adult hippocampus. A common set of differentially expressed genes, likely causal to the cognitive deficits, will be determined by comparing these two models. These models will provide important insights into DAND, as well as other developmental disorders with overlapping clinical phenotypes.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
